A NOVEL AI TOOL IS ACCURATE AT INTERPRETING HISTOLOGY AND DETECTS RESPONSE TO NEIHULIZUMAB THERAPY IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: PROOF OF CONCEPT

neihulizumab (ALTB-168) - AltruBio

David T. Rubin4; Jamshid Dehmeshki1,3; Jesse Hall2; Iming Cho2; Evelyn Chiang2; Shih-Yao Lin2; Simon Hart1; Olga Kubassova1

Mar 24, 2023